Evaluation of serum thymidine kinase 1 activity as a biomarker for treatment effectiveness and prediction of relapse in dogs with non‐Hodgkin lymphoma

BACKGROUND: Serum thymidine kinase 1 (sTK1) activity is closely correlated with DNA synthesis. OBJECTIVES: Evaluate sTK1 activity as a biomarker for treatment response and early detection of relapse in dogs with lymphoma. ANIMALS: Ninety‐seven client‐owned dogs with naive or relapsed lymphoma and 23...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyé, Pierre, Floch, Franck, Serres, François, Geeraert, Kévyn, Clerson, Pierre, Siomboing, Xavier, Bergqvist, Mattias, Sack, Gabriel, Tierny, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639481/
https://www.ncbi.nlm.nih.gov/pubmed/31129922
http://dx.doi.org/10.1111/jvim.15513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639481/
https://www.ncbi.nlm.nih.gov/pubmed/31129922
http://dx.doi.org/10.1111/jvim.15513

Ejemplares similares